| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |